The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
uh and so i see level one medicines level two medicines level three medicines and there's a bit of a hierarchy and an order in size and scope and scale ease of use likelihood of benefit uh and i would put mdma and psilocybin both in that level one category because they're both pretty forgiving uh you can have the high likelihood of an effective safe experience with a sitter uh using each of those in the right context
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.